Skip to content
PubMed This is a summary of 15 peer-reviewed journal articles Updated
Gallbladder Polyps in Primary Sclerosing Cholangitis

When Should PSC Patients Have Gallbladder Polyps Removed?

At a Glance

Because Primary Sclerosing Cholangitis (PSC) increases the risk of gallbladder cancer, doctors recommend removing the gallbladder for much smaller polyps—often starting at 8 millimeters—compared to the general population. Rapid growth or polyps of any size may also warrant surgery.

If you have Primary Sclerosing Cholangitis (PSC) and your doctor recommends removing your gallbladder because of a small polyp, it is natural to feel alarmed. In the general public, small polyps are very common and usually left alone. However, doctors treat gallbladder polyps differently in PSC patients because the condition carries a significantly higher risk of gallbladder cancer [1][2]. While a 5-millimeter polyp might just be watched in someone without liver disease, major medical guidelines recommend proactively removing the gallbladder (cholecystectomy) in PSC patients [1][3]. This approach aims to safely remove the polyp before it has the chance to become cancerous.

Why the Rules Are Different for PSC

In the general population, gallbladder polyps are relatively common and usually harmless. Doctors typically only recommend surgery if a polyp grows larger than 10 millimeters [4][5].

However, PSC is a recognized high-risk factor for biliary tract and gallbladder malignancies [6][7]. Research shows that when gallbladder polyps are found in people with PSC, they are much more likely to be malignant (cancerous) or pre-cancerous [1][8]. Because of this elevated risk, the standard rules do not apply, and international guidelines mandate a much lower threshold for surgical intervention [8][9].

Current Size Thresholds and Guidelines

The exact size that triggers a recommendation for surgery can depend on your specific medical situation, but the threshold is always lower than for the general public:

  • The 8-Millimeter Threshold: Many liver experts and major guidelines, including the AASLD and EASL, recommend removing the gallbladder if a polyp reaches 8 millimeters [2][3].
  • The 6-to-9 Millimeter Range: Some European guidelines advise that surgery should be considered for polyps measuring between 6 and 9 millimeters, provided the patient is healthy enough for surgery [9][10].
  • Rapid Growth or Any Size: Historically, and in some current international guidelines, doctors suggest removing the gallbladder for a polyp of any size in a PSC patient due to the high risk [8]. Today, many doctors also look closely at whether a small polyp is growing quickly between scans, which is a strong warning sign that warrants immediate removal [1][11].

Balancing Cancer Risk with Surgery Risks

While removing the gallbladder is the best way to prevent cancer, it is not the right choice for every PSC patient. The decision must be personalized by weighing the size and growth of the polyp against your overall liver health [2].

If your PSC has progressed to advanced liver disease (such as cirrhosis, which is severe scarring of the liver), abdominal surgery becomes exceptionally dangerous. In these cases, the risks of the surgery itself might outweigh the risk of the polyp becoming cancerous [12][13]. This is why your doctor will carefully evaluate your liver health before recommending surgery.

How You Are Monitored

Because gallbladder polyps cannot be safely biopsied while still inside the body, doctors rely on imaging to monitor them. If you have PSC, clinical practice guidelines recommend routine surveillance imaging—usually an abdominal ultrasound, CT scan, or MRI—every 6 to 12 months [2][14]. Note that for a gallbladder ultrasound, you will typically need to fast for several hours beforehand so the gallbladder is full and easier to see.

If a very tiny polyp (for example, 3 millimeters) is found, your doctor might recommend repeating the ultrasound in 3 to 6 months to check for growth before jumping straight to surgery [15][1].

What Gallbladder Removal Means for You

Since PSC already affects how bile flows through your liver, a common concern is how removing your gallbladder (which stores bile) will impact your digestion. Fortunately, your liver will continue to produce bile to help digest fats. Because the surgery is usually performed through small incisions (laparoscopically), recovery is often straightforward, though some patients temporarily need to eat smaller, less fatty meals as their body adjusts. Most importantly, your care team will help you manage any digestive changes and ensure the surgery is only performed if your liver is healthy enough to handle it [2][12].

Common questions in this guide

Why are gallbladder polyps treated differently if I have PSC?
People with Primary Sclerosing Cholangitis (PSC) have a significantly higher risk of developing gallbladder cancer. Because of this elevated risk, doctors are much more proactive and will recommend surgery for smaller polyps to prevent them from becoming cancerous.
At what size does a gallbladder polyp need to be removed in PSC?
Most major medical guidelines recommend removing the gallbladder if a polyp reaches 8 millimeters in a PSC patient. However, surgery may be considered for polyps between 6 and 9 millimeters, or even smaller if they are growing rapidly between scans.
How often should my gallbladder be checked if I have PSC?
If you have PSC, clinical guidelines recommend routine surveillance imaging every 6 to 12 months. This is typically done using an abdominal ultrasound, CT scan, or MRI to watch for new polyps or check if existing ones have grown.
What if I have advanced liver disease and a gallbladder polyp?
If your PSC has progressed to advanced liver disease like cirrhosis, abdominal surgery becomes exceptionally dangerous. In these cases, your doctor will carefully evaluate your liver health to determine if the risks of the surgery outweigh the risk of the polyp becoming cancerous.
Will I have trouble digesting food after my gallbladder is removed?
Your liver will continue to produce bile to help digest fats, even without a gallbladder to store it. While your body adjusts, you may need to temporarily eat smaller, less fatty meals, but most patients adapt to these changes without long-term digestive issues.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What is the exact size of my polyp, and how does it compare to previous scans?
  2. 2.Given my current liver health and PSC stage, am I a safe candidate for gallbladder surgery?
  3. 3.If we decide to remove my gallbladder, what changes can I expect to my daily diet and digestion?
  4. 4.Is my polyp showing any mass-like features or rapid growth that would make immediate surgery urgent?
  5. 5.How will my cancer screening and imaging plan change after my gallbladder is gone?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (15)
  1. 1

    Risk of gallbladder cancer in patients with primary sclerosing cholangitis and radiographically detected gallbladder polyps.

    van Erp LW, Cunningham M, Narasimman M, et al.

    Liver international : official journal of the International Association for the Study of the Liver 2020; (40(2)):382-392 doi:10.1111/liv.14326.

    PMID: 31823479
  2. 2

    AGA Clinical Practice Update on Surveillance for Hepatobiliary Cancers in Patients With Primary Sclerosing Cholangitis: Expert Review.

    Bowlus CL, Lim JK, Lindor KD

    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2019; (17(12)):2416-2422 doi:10.1016/j.cgh.2019.07.011.

    PMID: 31306801
  3. 3

    Ultrasound for the Detection of Gallbladder Malignancy in Primary Sclerosing Cholangitis.

    Altenmüller J, Wiegard C, Sebode M, et al.

    Liver international : official journal of the International Association for the Study of the Liver 2025; (45(9)):e70312 doi:10.1111/liv.70312.

    PMID: 40856347
  4. 4

    Revised Guidelines for the Treatment and Follow-Up of Gallbladder Polyps Do Not Reduce Unwarranted Cholecystectomies: Results of the POLYP Study.

    van Dooren M, de Savornin Lohman EAJ, van der Bilt J, et al.

    United European gastroenterology journal 2025; (13(7)):1133-1140 doi:10.1002/ueg2.70057.

    PMID: 40697033
  5. 5

    Society of Radiologists in Ultrasound Consensus Conference Recommendations for Incidental Gallbladder Polyp Management: Interreader Agreement Among 10 Radiologists.

    Anderson MA, Mercaldo S, Cao J, et al.

    AJR. American journal of roentgenology 2024; (222(5)):e2330720 doi:10.2214/AJR.23.30720.

    PMID: 38353447
  6. 6

    Biliary Tract Malignancies Related to Gallbladder Polyps, Primary Sclerosing Cholangitis, and Choledochal Cysts.

    Zia HA, Siddiqui UD

    Clinical liver disease 2021; (18(2)):85-89 doi:10.1002/cld.1101.

    PMID: 34584674
  7. 7

    Primary Sclerosing Cholangitis-Associated Cholangiocarcinoma: From Pathogenesis to Diagnostic and Surveillance Strategies.

    Catanzaro E, Gringeri E, Burra P, Gambato M

    Cancers 2023; (15(20)) doi:10.3390/cancers15204947.

    PMID: 37894314
  8. 8

    Risk assessment of gallbladder cancer in patients with primary sclerosing cholangitis and gallbladder polyps: a systematic review.

    Grikyte I, Ignatavicius P

    Langenbeck's archives of surgery 2025; (410(1)):216 doi:10.1007/s00423-025-03678-9.

    PMID: 40632214
  9. 9

    Management and follow-up of gallbladder polyps: updated joint guidelines between the ESGAR, EAES, EFISDS and ESGE.

    Foley KG, Lahaye MJ, Thoeni RF, et al.

    European radiology 2022; (32(5)):3358-3368 doi:10.1007/s00330-021-08384-w.

    PMID: 34918177
  10. 10

    [Recent Updates on Management and Follow-up of Gallbladder Polyps].

    Son JH

    The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 2023; (81(5)):197-202 doi:10.4166/kjg.2023.038.

    PMID: 37226819
  11. 11

    The management of gallbladder polyps.

    Valibouze C, El Amrani M, Truant S, et al.

    Journal of visceral surgery 2020; (157(5)):410-417 doi:10.1016/j.jviscsurg.2020.04.008.

    PMID: 32473822
  12. 12

    Cirrhosis and age are key determinants of HCC risk in individuals with primary sclerosing cholangitis: A multicenter longitudinal cohort study.

    Holmer M, Ingre M, Färkkilä M, et al.

    Hepatology (Baltimore, Md.) 2026; (83(1)):21-29 doi:10.1097/HEP.0000000000001351.

    PMID: 40238209
  13. 13

    Primary Sclerosing Cholangitis, Part 2: Cancer Risk, Prevention, and Surveillance.

    Tabibian JH, Ali AH, Lindor KD

    Gastroenterology & hepatology 2018; (14(7)):427-432.

    PMID: 30166959
  14. 14

    Prospective surveillance for cholangiocarcinoma in unselected individuals with primary sclerosing cholangitis.

    Villard C, Friis-Liby I, Rorsman F, et al.

    Journal of hepatology 2023; (78(3)):604-613 doi:10.1016/j.jhep.2022.11.011.

    PMID: 36410555
  15. 15

    Survey uncovering variations in the management of primary sclerosing cholangitis across Europe.

    Eliasson J, Lo B, Schramm C, et al.

    JHEP reports : innovation in hepatology 2022; (4(11)):100553 doi:10.1016/j.jhepr.2022.100553.

    PMID: 36164416

This page explains gallbladder polyp guidelines in PSC for informational purposes only. Always consult your hepatologist, gastroenterologist, or surgeon regarding your specific liver health and treatment options.

Get notified when new evidence is published on Primary sclerosing cholangitis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.